ANDA 71405, held by Natco. Trazodone Hydrochloride.
As of Nov 16, 2026, ANDA 71405 (Trazodone Hydrochloride), held by Natco, was first approved by FDA on Feb 27, 1991, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 27, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trazodone Hydrochloride50MG · tablet;oral | Trazodone Hydrochloride | Discontinued |
| Jun 24, 2025 | Supplement 8Labeling · Standard review | Approved | None posted |
| Apr 29, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Feb 5, 1998 | Supplement 4Manufacturing | Approved | None posted |
| Jan 14, 1992 | Supplement 2Labeling | Approved | None posted |
| Oct 28, 1991 | Supplement 1Manufacturing | Approved | None posted |
| Feb 27, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters